The blood–brain barrier is playing a critical role in controlling the influx and efflux of
biological substances essential for the brain's metabolic activity as well as neuronal function …

The disruption of blood–brain barrier (BBB) for multiple sclerosis (MS) pathogenesis has a
double effect: early on during the onset of the immune attack and later for the CNS self …

Multiple sclerosis (MS) is an autoimmune disease of the central nervous system associated
with demyelination and axonal loss eventually leading to neurodegeneration. MS exhibits …

Neurodegeneration describes the loss of neuronal structure and function. Numerous
neurodegenerative diseases are associated with neurodegeneration. Many are rare and …

Multiple sclerosis (MS) exhibits many of the hallmarks of an inflammatory autoimmune
disorder including breakdown of the blood‐brain barrier (BBB), the recruitment of …

Reactive oxygen species (ROS) are oxidizing agents amply implicated in tissue damage.
ROS production is inevitably linked to ATP synthesis in most cells, and the rate of production …

Multiple sclerosis (MS) is a chronic inflammatory disease, which leads to focal plaques of
demyelination and tissue injury in the central nervous system (CNS). Neuroinflammation …

Multiple sclerosis (MS) is a chronic inflammatory disease, which leads to focal plaques of
demyelination and tissue injury in the central nervous system. Oxidative stress is also …

Leakage of the blood–brain barrier (BBB) is a common pathological feature in multiple
sclerosis (MS). Following a breach of the BBB, albumin, the most abundant protein in …

We aimed to investigate the extent of alterations in the pro/antioxidant balance in the blood
of patients with relapsing–remitting multiple sclerosis (RRMS) in relation to drug-modified …